An investigation of breast cancer risk factors in Cyprus: A case control study

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Hadjisavvas, Andreas ^a   Loizidou, Maria A ^a   Middleton, Nicos ^b   Michael, Thalia ^a   Papachristoforou, Rena ^a   Kakouri, Eleni ^c   Daniel, Maria ^c   Papadopoulos, Panayiotis ^c   Malas, Simon ^d   Marcou, Yiola ^c   Kyriacou, Kyriacos ^a  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b CYPRUS UNIVERSITY OF TECHNOLOGY   (Cyprus)

^c Bank of Cyprus Group Oncology Centre   (Cyprus)

^d LIMASSOL GENERAL HOSPITAL   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; BREAST FEEDING; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; CYPRUS; DEMOGRAPHY; EDUCATIONAL STATUS; ENVIRONMENTAL FACTOR; EXERCISE; FAMILY HISTORY; FEMALE; HEALTH PROGRAM; HEREDITY; HORMONE SUBSTITUTION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MARRIAGE; MENARCHE; PARITY; PREDICTION; PREGNANCY; RISK ASSESSMENT; RISK FACTOR; BREAST TUMOR; COMPARATIVE STUDY; INCIDENCE; MIDDLE AGED; SURVIVAL RATE;

ADULT; AGED; BREAST FEEDING; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYPRUS; FEMALE; HUMANS; INCIDENCE; MENARCHE; MIDDLE AGED; PREGNANCY; RISK FACTORS; SURVIVAL RATE;

EID: 77955810166     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-447     Document Type: Article

References (35)

1. Lippman ME. Breast cancer. Harrison's Principles of Internal Medicine 2001, 572. New York City: McGraw-Hill Professional Publishing, Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, 15.
2. Kelsey JL, Horn-Ross PL. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 1993, 15:7-16.
3. Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am J Epidemiol 1994, 139:819-835.
4. Lipworth I. Epidemiology of breast cancer. Eur J Cancer Prev 1995, 4:7-30. 10.1097/00008469-199502000-00002, 7537139.
5. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. The Lancet Oncology 2001, 2:133-140. 10.1016/S1470-2045(00)00254-0, 11902563.
6. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
7. Wrensch M, Chew T, Farren G, Barlow J, Belli F, Clarke C, Erdmann CA, Lee M, Moghadassi M, Peskin-Mentzer R, Quesenberry CP, Souders-Mason V, Spence L, Suzuki M, Gould M. Risk factors for breast cancer in a population with high incidence rates. Breast Cancer Research 2003, 5:R88-102. 10.1186/bcr605, 165017, 12817999.
8. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266:66-71. 10.1126/science.7545954, 7545954.
9. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gumbs C, Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378:789-792. 10.1038/378789a0, 8524414.
10. McPherson K, Stell CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 2000, 321:624-628. 10.1136/bmj.321.7261.624, 1118507, 10977847.
11. Rennert G. Breast Cancer Chapter 8. MECC Monograph 2006, 73-81. Bethesda: NIH Pub. No. 06-5873, Freedman LS, Edwards BK, Ries LA, Young JL.
12. Hadjisavvas A, Charalambous E, Adamou A, Neuhausen SL, Christodoulou CG, Kyriacou K. Hereditary breast and ovarian cancer in Cyprus: identification of a founder BRCA2 mutation. Cancer Genet Cytogenet 2004, 151:152-156. 10.1016/j.cancergencyto.2003.09.020, 15172753.
13. Loizidou M, Marcou Y, Anastasiadou V, Newbold R, Hadjisavvas A, Kyriacou K. Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early onset breast cancer in Cyprus. Clin Genet 2007, 71:165-170. 10.1111/j.1399-0004.2007.00747.x, 17250666.
14. Anglian Breast Cancer Study Group Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 2000, 83:1301-8. 10.1054/bjoc.2000.1407, 2408797, 11044354, Anglian Breast Cancer Study Group.
15. Rastogi T, Hildesheim A, Sinha R. Opportunities for cancer epidemiology in developing countries. Nat Rev Cancer 2004, 4:909-917. 10.1038/nrc1475, 15516963.
16. dos Santos Silva I. Case-control studies. Cancer Epidemiology: Principles and Methods 1999, 189-212. IARC Press, dos Santos Silva I. Lyon.
17. Ebrahimi M, Vahdaninia M, Montazeri A. Risk factors for breast cancer in Iran: a case-control study. Breast Cancer Res 2002, 4(5):R10. 10.1186/bcr454, 125302, 12223127.
18. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993, 15:110-132.
19. Collaborative Group on Hormonal Factors in Breast Cancer Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001, 358:1389-1399. 10.1016/S0140-6736(01)06524-2, 11705483, Collaborative Group on Hormonal Factors in Breast Cancer.
20. Thompson D, Easton D. The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 2004, 9:221-236. 10.1023/B:JOMG.0000048770.90334.3b, 15557796.
21. Dumitrescu RG, Cotarla I. Understanding breast cancer risk - where do we stand in 2005?. J Cell Mol Med 2005, 9:208-221. 10.1111/j.1582-4934.2005.tb00350.x, 15784178.
22. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993, 15:36-47.
23. Kelsey JL, Horn-Ross PL. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 1993, 15:7-16.
24. Ferguson DJ, Anderson TJ. Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br J Cancer 1981, 44:177-181. 2010743, 7272186.
25. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993, 15:17-35.
26. Lipworth L, Bailey LR, Trichopoulos D. History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst 2000, 92:302-312. 10.1093/jnci/92.4.302, 10675379.
27. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002, 360:187-195. 10.1016/S0140-6736(02)09454-0, 12133652, Collaborative Group on Hormonal Factors in Breast Cancer.
28. Russo J, Russo IH. The etiopathogenesis of breast cancer prevention. Cancer Lett 1995, 90:81-89. 10.1016/0304-3835(94)03681-8, 7720046.
29. Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC. Do regular ovulatory cycles increase breast cancer risk?. Cancer 1985, 56:1206-1208. 10.1002/1097-0142(19850901)56:5<1206::AID-CNCR2820560541>3.0.CO;2-9, 4016708.
30. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997, 350:1047-1059. 10.1016/S0140-6736(97)08233-0, 10213546, Collaborative Group on Hormonal Factors in Breast Cancer.
31. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333. 10.1001/jama.288.3.321, 12117397, Writing Group for the Women's Health Initiative Investigators.
32. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr M, Thomson CA, Khandekar J, Petrovitch H, McTiernan A, . for the WHI Investigators Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomised trial. JAMA 2003, 289:3243-3253. 10.1001/jama.289.24.3243, 12824205, for the WHI Investigators.
33. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002, 360:942-944. 10.1016/S0140-6736(02)11032-4, 12354487.
34. Beral V, . Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362:419-427. 10.1016/S0140-6736(03)14596-5, 12927427, Million Women Study Collaborators.
35. Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 2000, 92:328-332. 10.1093/jnci/92.4.328, 10675382.